Integrating liquid biopsies into the management of cancer
During cancer progression and treatment, multiple subclonal populations of tumour cells
compete with one another, with selective pressures leading to the emergence of …
compete with one another, with selective pressures leading to the emergence of …
Progress and prospects of early detection in lung cancer
Lung cancer is the leading cause of cancer-related death in the world. It is broadly divided
into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx …
into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx …
Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence
AB Chinen, CM Guan, JR Ferrer, SN Barnaby… - Chemical …, 2015 - ACS Publications
Cancer is the second most common cause of death in the United States, trailing only heart
disease in incidence. Despite significant worldwide investment in research, cancer remains …
disease in incidence. Despite significant worldwide investment in research, cancer remains …
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
L Harris, H Fritsche, R Mennel, L Norton… - Journal of clinical …, 2007 - ascopubs.org
Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an …
screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an …
Blood-based cancer biomarkers in liquid biopsy: a promising non-invasive alternative to tissue biopsy
Cancer is one of the greatest threats facing our society, being the second leading cause of
death globally. Currents strategies for cancer diagnosis consist of the extraction of a solid …
death globally. Currents strategies for cancer diagnosis consist of the extraction of a solid …
Circulating tumor cells: approaches to isolation and characterization
Circulating tumor cells (CTCs) shed from primary and metastatic cancers are admixed with
blood components and are thus rare, making their isolation and characterization a major …
blood components and are thus rare, making their isolation and characterization a major …
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
CL Hodgkinson, CJ Morrow, Y Li, RL Metcalf… - Nature medicine, 2014 - nature.com
Small-cell lung cancer (SCLC), an aggressive neuroendocrine tumor with early
dissemination and dismal prognosis, accounts for 15–20% of lung cancer cases and∼ …
dissemination and dismal prognosis, accounts for 15–20% of lung cancer cases and∼ …
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system
S Riethdorf, H Fritsche, V Müller, T Rau… - Clinical cancer …, 2007 - AACR
Abstract Purpose: The CellSearch system (Veridex, Warren, NJ) is designed to enrich and
enumerate circulating tumor cells (CTCs) from peripheral blood. Here, we validated the …
enumerate circulating tumor cells (CTCs) from peripheral blood. Here, we validated the …
Prognostic and predictive biomarkers in breast cancer: Past, present and future
Following a diagnosis of breast cancer, the most immediate challenges in patient
management are the determination of prognosis and identification of the most appropriate …
management are the determination of prognosis and identification of the most appropriate …
[HTML][HTML] Circulating tumor cell technologies
Circulating tumor cells, a component of the “liquid biopsy”, hold great potential to transform
the current landscape of cancer therapy. A key challenge to unlocking the clinical utility of …
the current landscape of cancer therapy. A key challenge to unlocking the clinical utility of …